This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.
Individuals with a severely painful and/or disabling hip joint with osteoarthritis, traumatic arthritis or developmental dysplasia of the hip or avascular necrosis of the femoral head.
In order to take part in this study, all study participants must be between the ages of 18 and 75 years of age, at the time of surgery.
Scheduled for a primary total hip replacement.
Active infection
Pregnancy
Mental illness where the known condition is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress or complete the 10 year cycle of follow-up appointments and reviews
Grossly distorted anatomy (surgeon's discretion)
Individuals suitable for hip replacement using the Medacta SMS femoral stem
Cohort
Prospective
SMS femoral stem
Devicesurvivorship of the Medacta SMS femoral stem
clinical performance
Harris Hip Score
radiographic performance
presence of radiolucencies
Evaluate the patient satisfaction
Oxford score
Evaluate the quality of life
EQ-5D
Click on the lead sponsor to view all of their trials.
